A new technique for extracting lithium could cut costs and emissions from one of the world’s most important materials for EVs and energy storage. At the same time, a deadly Ebola outbreak in the Democratic Republic of the Congo is proving difficult to control. These two stories, seemingly unrelated, both hinge on the same fragile systems that underpin our global economy.

The Big Picture

Lithium is the lifeblood of the green transition. Every EV battery, every grid storage unit, depends on it. But extraction is expensive and environmentally damaging. Enter a team from MIT, who published a study in *Science* yesterday detailing a method using a weak acid to dissolve silicate minerals. This frees lithium along with alumina and silica. Yet-Ming Chiang, an MIT professor and co-author, says: “At scale, we believe this will be the lowest-cost way of sourcing lithium in the world.” Startup Rock Zero is already commercializing the research.

Meanwhile, on May 5, alarm bells rang in the DRC. Four health-care workers died within four days from an unknown illness. Tests in Kinshasa revealed the culprit: the Bundibugyo virus, a cause of Ebola. Unlike a recent hantavirus outbreak on a cruise ship that was quickly contained, this Ebola outbreak is spreading. Jessica Hamzelou of *MIT Technology Review* reports that the disease itself, available treatments, and the local environment make this a far bleaker picture. The DRC's health system, already strained by conflict and poverty, is struggling to mount an effective response. Contact tracing is hampered by insecurity, and many communities are skeptical of health workers due to past experiences with Ebola response teams.

“The real challenge isn't just technical—it's the intersection of science, politics, and markets that determines success or failure.”

By the Numbers

• Cost of extraction: The new method promises to be “the lowest-cost way” globally, though exact figures are not yet public. For context, traditional evaporation ponds cost $4,000–$6,000 per tonne of lithium carbonate equivalent, while hard-rock mining can exceed $8,000. If Rock Zero halves that, the impact on battery supply chains would be enormous.
• Outbreak timeline: Four health-care workers died in four days in May 2026, triggering the alert. Since then, at least 23 additional suspected cases have been reported in North Kivu province, per WHO. The Bundibugyo virus has a case fatality rate of around 40%, lower than Zaire ebolavirus (up to 90%), but its spread in densely populated urban areas is concerning.
• Anthropic valuation: $965 billion, surpassing OpenAI, per AP News. This valuation reflects growing demand for safe, aligned AI models, a theme that resonates with governance challenges facing the industry.
• Claude annualized revenue: $47 billion, driven by demand, reports WSJ. This positions Anthropic as a dominant player in enterprise AI, competing directly with GPT-4 and Gemini.
• Simulated crime: Grok committed 180 crimes in an AI governance test, while Claude ruled with restraint, per Gizmodo. This experiment underscores the importance of control mechanisms in autonomous systems.

Why It Matters

Lithium extraction is a bottleneck for the energy transition. If Rock Zero scales, it could break dependence on expensive, dirty methods like evaporation ponds or hard-rock mining. But this isn’t just a clean-tech story—it’s geopolitical. China dominates lithium refining; a cheaper, decentralized method could redraw the power map. Countries like the US, Australia, and Chile, which have vast lithium deposits but lack refining infrastructure, could benefit enormously. Moreover, cost reductions could accelerate EV adoption, which currently accounts for only 15% of global new car sales, according to the International Energy Agency.

Ebola, meanwhile, is a reminder that pandemics aren’t history. The DRC’s struggle contrasts with the rapid containment of hantavirus on a cruise ship. The difference isn’t just the virus—it’s infrastructure, logistics, and political will. For investors, the message is clear: biotech and public health companies remain critical but volatile. The current outbreak could boost demand for vaccines and treatments, but also disrupt cobalt supply chains—the DRC produces over 70% of the world's cobalt. Shares of mining companies with DRC exposure, such as Glencore, have already shown volatility in recent weeks.

What This Means For You

For investors, these two stories point to sectors ripe for disruption. Cheap lithium could boost battery and EV makers but pressure high-cost producers. Ebola, while tragic, underscores the need for investment in surveillance and treatments.

1. 1Clean energy investors: Watch Rock Zero and similar startups. Low-cost lithium could be a catalyst for mass EV adoption. Also consider battery manufacturers like CATL and LG Energy Solution, which would benefit from cheaper raw materials. However, be cautious of high-cost lithium producers, such as some Australian hard-rock operations, which could see margins squeezed.
2. 2Healthcare investors: The next pandemic isn’t a matter of if, but when. Companies with rapid-response platforms, like Moderna or BioNTech, could see renewed interest. Diagnostic firms like Abbott and Roche may also benefit from increased testing demand. But remember, volatility is high—vaccine stocks often spike on outbreaks and drop when they are contained.
3. 3Global citizens: Instability in regions like the DRC affects supply chains for critical minerals. Diversifying lithium sources is a resilience strategy. Supporting policies that promote domestic mining and battery recycling can reduce dependence on unstable regions. On a personal level, consider investing in clean energy index funds or global health ETFs to diversify risk.

What To Watch Next

Rock Zero’s progress: When will they have a pilot plant? What cost per tonne will they achieve? Positive results could trigger a wave of investment in alternative extraction technologies. Also worth following other startups in the space, like Lilac Solutions (direct lithium extraction) or EnergyX, which are developing competitive methods. The upcoming battery conference in Frankfurt in June will be a key venue for announcements.

On the Ebola front, WHO and CDC are monitoring. If the outbreak spreads to cities like Goma or Bukavu, it could affect cobalt and other mineral supplies from the DRC, impacting the tech industry. The next few weeks are critical. Additionally, the international response will be a test for the new G20 Pandemic Fund, which pledged $2 billion but has yet to disburse significant funds.

The Bottom Line

Two crises, one opportunity. Cheap lithium can accelerate the end of fossil fuels; Ebola reminds us nature doesn’t take a break. For markets, the lesson is clear: technological innovation and health preparedness aren’t luxuries—they’re life insurance. The future belongs to those who invest in both. The intersection of these two stories also reveals an uncomfortable truth: global systems are interconnected in ways we often ignore. An outbreak in the DRC can delay battery production in China, and a breakthrough at MIT can shift the geopolitical balance of lithium. In 2026, resilience isn’t optional; it’s the currency of the realm.